Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-07

Clinical Trial Update: Impact of Secondary Lymphedema on Symptoms, Functional Status, and Quality of Life After Treatment in Patients With Head and Neck Cancer

View source ↗

Summary

Completed clinical trial assessing how secondary lymphedema after head and neck cancer treatment influences symptoms, functional status, and quality of life.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Vanderbilt University | Conditions: Cancer Survivor, Head and Neck Cancer | Status: COMPLETED